» Articles » PMID: 30445355

Altered Profiles and Metabolism of L- and D-amino Acids in Cultured Human Breast Cancer Cells Vs. Non-tumorigenic Human Breast Epithelial Cells

Overview
Specialty Chemistry
Date 2018 Nov 17
PMID 30445355
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Herein we describe for the first time the endogenous levels of free l-and d-amino acids in cultured human breast cancer cells (MCF-7) and non-tumorigenic human breast epithelial cells (MCF-10A). d-Asp and d-Ser, which are co-agonists of the N-methyl-d-aspartate (NMDA) receptors, showed significantly elevated levels in MCF-7 cancer cells compared to MCF-10A cells. This may result from upregulated enzymatic racemases. Possible roles of these d-amino acids in promoting breast cancer proliferation by regulating NMDA receptors were indicated. d-Asn may also be able to serve as exchange currency, like specific l-amino acids, for the required uptake of essential amino acids and other low abundance nonessential amino acids which were elevated nearly 60 fold in cancer cells. The relative levels of specific l- and d-amino acids can be used as malignancy indicators (MIs) for the breast cancer cell line in this study. High MIs (>50) result from the increased demands of specific essential amino acids. Very low MIs (<1) result from the increased demands of specific d-amino acids (i.e., d-Ser, d-Asp) or the cellular release of amino acid exchange currency (i.e., l- and d-Asn) used in the upregulated amino acid antiporters to promote cancer cell proliferation.

Citing Articles

Effect of D-amino acid metabolic enzyme deficiency on cancer development-diffuse large B-cell lymphoma onset and gene expression analyses in DASPO-knockout mice.

Nakade Y, Iwata Y, Harada K, Sato Y, Mita M, Hamase K Amino Acids. 2024; 57(1):4.

PMID: 39718666 PMC: 11668858. DOI: 10.1007/s00726-024-03426-1.


Plant Metabolomics: The Future of Anticancer Drug Discovery.

Dabbousy R, Rima M, Roufayel R, Rahal M, Legros C, Sabatier J Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458949 PMC: 11510165. DOI: 10.3390/ph17101307.


Advances in Chiral Metabolomic Profiling and Biomarker Discovery.

Pandey R, Tiziani S Methods Mol Biol. 2024; 2855:85-101.

PMID: 39354302 DOI: 10.1007/978-1-0716-4116-3_5.


Exploration of the intracellular chiral metabolome in pediatric BCP-ALL: a pilot study investigating the metabolic phenotype of IgH locus aberrations.

Collins M, Gorgoglione R, Impedovo V, Pan X, Chakkarai S, Yi S Front Oncol. 2024; 14:1413264.

PMID: 39161381 PMC: 11332069. DOI: 10.3389/fonc.2024.1413264.


Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection.

Li K, Gilberti A, Marden J, Akula H, Pollard A, Guo S J Med Chem. 2024; 67(12):10293-10305.

PMID: 38838188 PMC: 11258582. DOI: 10.1021/acs.jmedchem.4c00774.